– Interview with Sebastian Maurer-Stroh, Ph.D., Principal Investigator, Bioinformatics Institute, Biopolis, Singapore

Previous articleCangene to Use Upfront’s Platform to Produce Antibodies from Plasma
Next articleMDRNA Revises Agreement with RiboTask for UNA Technology